{"title":"Volume 15","authors":"","doi":"10.1111/jdi.14374","DOIUrl":null,"url":null,"abstract":"<p>50-g Oral glucose challenge test</p><p>Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.</p><p>β-Cell dysfunction</p><p>Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.</p><p>β-Cells</p><p>Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.</p><p>β-Cell mass</p><p>Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.</p><p>Accuracy</p><p>Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.</p><p>Acyl-coenzyme A synthetase long-chain family member 4</p><p>Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.</p><p>Adherence</p><p>Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.</p><p>Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.</p><p>Aging</p><p>Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.</p><p>Alcohol drinking</p><p>The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.</p><p>Aldehyde dehydrogenase 2</p><p>Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.</p><p>Algorithm</p><p>A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes—2nd edition (English version), Bouchi 1326–1342.</p><p>Alzheimer's disease-like complications of DM</p><p>Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.</p><p>Angiopoietin-like 4</p><p>Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.</p><p>Antidiabetic drugs</p><p>Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.</p><p>Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.</p><p>Anti-inflammatory activity</p><p>High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.</p><p>Anti-oxidative activity</p><p>High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.</p><p>Area under the C-peptide curve</p><p>Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.</p><p>Arginine vasopressin deficiency</p><p>Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.</p><p>Arterial stiffness</p><p>Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.</p><p>Asia</p><p>Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.</p><p>Aspirin</p><p>Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.</p><p>Asprosin</p><p>The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.</p><p>Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.</p><p>Asthma</p><p>A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.</p><p>Atherosclerosis</p><p>High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.</p><p>Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.</p><p>Autoimmunity</p><p>Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.</p><p>Autophagy</p><p>Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.</p><p>Average age at death</p><p>Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.</p><p>Average real variability</p><p>Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.</p><p>Behavioral change</p><p>Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.</p><p>Beta-cell function</p><p>Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.</p><p>Bioinformatics</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Bioinformatics analysis</p><p>Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.</p><p>Biomarker</p><p>Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.</p><p>Biomarkers</p><p>The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Birth weight</p><p>Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.</p><p>Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.</p><p>Blind</p><p>Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.</p><p>Blood glucose</p><p>Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.</p><p>Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.</p><p>A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.</p><p>Blood glucose monitors</p><p>Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.</p><p>Body composition</p><p>Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.</p><p>Body mass index</p><p>Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.</p><p>Calpain-2</p><p>Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.</p><p>Cancer</p><p>Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.</p><p>Cardio-ankle vascular index</p><p>Systematic Coronary Risk Evaluation 2-Diabetes risk.</p><p>Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.</p><p>Cardiovascular autonomic neuropathy</p><p>Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.</p><p>Cardiovascular disease</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.</p><p>Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.</p><p>Cardiovascular diseases</p><p>Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.</p><p>Casual blood glucose</p><p>Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.</p><p>Cause of death</p><p>Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.</p><p>CCP</p><p><i>Cordyceps cicadae</i> polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.</p><p>Cell encapsulation</p><p>Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.</p><p>Cesarean</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Children</p><p>Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.</p><p>Children and adolescents</p><p>Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.</p><p>China</p><p>Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.</p><p>Chinese Han population</p><p>Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.</p><p>Cholesterol efflux</p><p>High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.</p><p>Chorea</p><p>Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.</p><p>Chronic kidney disease</p><p>Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.</p><p>Chronic kidney disease progression</p><p>Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.</p><p>Circ_0068087</p><p>Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.</p><p>Claims analysis</p><p>Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.</p><p>Claims data</p><p>Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.</p><p>Clinical</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Clinical epidemiology</p><p>Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.</p><p>Clopidogrel</p><p>Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.</p><p>Coefficient of variation</p><p>Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.</p><p>Coefficient of variation of R-R intervals</p><p>Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.</p><p>Cognition</p><p>Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.</p><p>Cognitive impairment</p><p>Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.</p><p>Cohort study</p><p>Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.</p><p>Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.</p><p>Combined approaches</p><p>Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.</p><p>Commentary</p><p>Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes, Takahashi 63–66.</p><p>Pituitary gland agouti-related peptide cells: Novel player controlling glucose metabolism, Takahashi 67–69.</p><p>Dipeptidyl peptidase-4 inhibition targeting vascular senescence as a novel treatment for atherosclerosis, Yen 143–144.</p><p>Glucose-dependent insulinotropic polypeptide receptor systems in the hypothalamus and the brainstem regulate feeding and weight through distinct pathways, Yada 283–284.</p><p>Advancements and challenges in pancreatic islet transplantation: Insights from the Collaborative Islet Transplant Registry, Lee 423–425.</p><p>Deciphering the causal tapestry between cardiorespiratory fitness and type 2 diabetes mellitus, Ko 426–428.</p><p>Birthweight and risk of diabetes in later life, Sheu 557–558.</p><p>Effects of dipeptidyl peptidase-4 inhibition <i>in vivo</i>: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management, Yasuda 704–706.</p><p>Gut microbiota dysbiosis as a novel pathogenic factor of diabetic peripheral neuropathy, Niimi 817–819.</p><p>Commentary on association of glycemic index and glycemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality, Hsieh 1545–1547.</p><p>Regulation of glucose and energy metabolism through actions of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, Zenimaru 1725–1726.</p><p>Commentary on “Intra-islet a-cell Gs signaling promotes glucagon release”, Kitamura 1727–1728.</p><p>Complications of diabetes</p><p>Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.</p><p>Continuous glucose monitoring</p><p>Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.</p><p>Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.</p><p>Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.</p><p>Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.</p><p>Possible etiological role of impaired endogenous double strand RNA editing in β-cells in type 1 diabetes, Imai 1171–1173.</p><p>A sneak peek into chronic glucose exposure and insulin secretion impairment through translatome, Helena 1174–1176.</p><p>Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.</p><p>Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.</p><p>Continuous subcutaneous insulin infusion</p><p>Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.</p><p>Corneal confocal microscopy</p><p>Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.</p><p>Cortisol</p><p>An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.</p><p>COVID-19</p><p>Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.</p><p>Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.</p><p>Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.</p><p>COVID-19 pandemic</p><p>Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.</p><p>C-peptide index</p><p>Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.</p><p>Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.</p><p>Critically ill</p><p>Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.</p><p>Cross-sectional studies</p><p>Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.</p><p>Cross-sectional study</p><p>Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.</p><p>CYP1B1</p><p>MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.</p><p>Cystatin C</p><p>Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.</p><p>Diabetes</p><p>Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.</p><p>Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.</p><p>Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.</p><p>Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.</p><p>Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.</p><p>Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.</p><p>Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.</p><p>Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.</p><p>Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.</p><p>Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.</p><p>Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.</p><p>Diabetes complications</p><p>Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.</p><p>Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.</p><p>Diabetes duration</p><p>Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.</p><p>Diabetes mellitus</p><p>Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.</p><p>Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.</p><p>Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.</p><p>Social deprivation and diabetic kidney disease: A European view, Casey 541–556.</p><p>Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.</p><p>Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.</p><p>Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.</p><p>Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.</p><p>Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.</p><p>Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.</p><p>Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.</p><p>A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.</p><p>A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.</p><p>Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.</p><p>Diabetes mellitus type 1</p><p>Islet transplantation in Korea, Lee 1165–1170.</p><p>Diabetes mellitus, type 2</p><p>Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.</p><p>Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.</p><p>PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.</p><p>Diabetes patient</p><p>Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.</p><p>Diabetes therapy-related quality of life</p><p>Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.</p><p>Diabetic cardiomyopathy</p><p><i>Polygonatum sibiricum</i> (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.</p><p>Regulatory T cells protect against diabetic cardiomyopathy in <i>db/db</i> mice, Zhang 1191–1201.</p><p>Diabetic complications</p><p>The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.</p><p>Diabetic education</p><p>Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.</p><p>Diabetic foot</p><p>What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.</p><p>Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.</p><p>Diabetic foot ulcer recurrence</p><p>Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.</p><p>Diabetic ketoacidosis</p><p>Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.</p><p>Diabetic kidney disease</p><p>Social deprivation and diabetic kidney disease: A European view, Casey 541–556.</p><p>Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.</p><p>Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.</p><p>Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.</p><p>Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.</p><p>Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.</p><p>Diabetic macular edema</p><p>Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.</p><p>Diabetic nephropathy</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.</p><p>METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.</p><p><i>Cordyceps cicadae</i> polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.</p><p>Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.</p><p>Diabetic neuropathy</p><p>Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.</p><p>Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.</p><p>Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.</p><p>Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.</p><p>Diabetic peripheral neuropathy</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Diabetic polyneuropathies</p><p>Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.</p><p>Diabetic retinopathy</p><p>Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.</p><p>Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.</p><p>Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.</p><p>Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.</p><p>Diabetic striatopathy</p><p>Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.</p><p>Diabetics with critical limb ischemia</p><p>Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.</p><p>Diabetic symmetric sensorimotor polyneuropathy</p><p>Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253</p><p>Diet</p><p>Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.</p><p>Dietary intervention</p><p>Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.</p><p>Dietary therapy</p><p>Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.</p><p>Digital platform</p><p>Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.</p><p>Doxorubicin</p><p>Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.</p><p>DPNCheck</p><p>Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.</p><p>East Asians</p><p>Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.</p><p>Eating behavior</p><p>An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.</p><p>Eating behaviors</p><p>Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.</p><p>Editorial</p><p>Common metabolite for microangiopathy in Japanese and European populations, Shojima 523–524.</p><p>The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigma, Seino 1533–1536.</p><p>The roles of output clock genes in regulating glucose metabolism, Taguchi 1707–1710.</p><p>Elderly</p><p>Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.</p><p>Embryonic lethal abnormal visual-like protein 1</p><p>Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.</p><p>Empagliflozin</p><p>Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.</p><p>EPAC</p><p>Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.</p><p>Epigenetic change</p><p>Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.</p><p>Epilepsy</p><p>Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.</p><p>Estimated glomerular filtration rate</p><p>Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.</p><p>Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.</p><p>Ethnicity</p><p>Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.</p><p>Executive function</p><p>Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.</p><p>Fasting plasma glucose</p><p>Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.</p><p>Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.</p><p>Fenofibrate</p><p>Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.</p><p>Flash glucose monitoring</p><p>Fresh autologous blood transfusion.</p><p>Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.</p><p>Foot ulcer</p><p>What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.</p><p>Frailty</p><p>Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.</p><p>Fulminant type 1 diabetes</p><p>Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.</p><p>GAD antibody</p><p>New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.</p><p>Gastrectomy</p><p>Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.</p><p>Gastrointestinal diseases</p><p>Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.</p><p>Gene editing</p><p>Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.</p><p>Generalized lipodystrophy</p><p>Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.</p><p>Genetic insulin resistance syndrome</p><p>A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.</p><p>Genetics and pathogenesis</p><p>Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.</p><p>Genome-wide association studies</p><p>Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.</p><p>Gestational diabetes</p><p>The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.</p><p>Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.</p><p>Gestational diabetes mellitus</p><p>Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.</p><p>Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.</p><p>Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.</p><p>Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.</p><p>Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.</p><p>Gestational weight gain</p><p>Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.</p><p>Glomerular filtration rate</p><p>Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.</p><p>Glucagon</p><p>Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.</p><p>Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.</p><p>Glucagon-like peptide-1</p><p>Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.</p><p>Glucagon-like peptide 1 receptor agonist</p><p>Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.</p><p>Glucogenic action</p><p>Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.</p><p>Glucokinase</p><p>Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.</p><p>Glucose</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Glucose metabolism</p><p>Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.</p><p>Glucose-stimulated insulin secretion</p><p>Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.</p><p>Glutamic acid decarboxylase.</p><p>Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.</p><p>Glycated albumin</p><p>Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.</p><p>Glycated hemoglobin</p><p>Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.</p><p>Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.</p><p>Glycemia risk index</p><p>Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.</p><p>Glycemic control</p><p>Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.</p><p>Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Glycemic metrics in Japanese isCGM users—Analysis by diabetes type and therapy, Ogawa 1483–1488.</p><p>Glycemic management</p><p>The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.</p><p>Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.</p><p>Glycemic variability</p><p>Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.</p><p>Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.</p><p>Glycosylated hemoglobin</p><p>Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.</p><p>Growth</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Handgrip strength</p><p>The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.</p><p>Haptoglobin</p><p>Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.</p><p>HbA1c</p><p>Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.</p><p>HbA1c degradation</p><p>Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.</p><p>HbA1c trajectory</p><p>Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.</p><p>HbA1c variability</p><p>Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.</p><p>Health care costs</p><p>Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.</p><p>Healthcare quality assessment</p><p>Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.</p><p>Health resources</p><p>Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.</p><p>Healthy volunteers</p><p>Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.</p><p>Heart failure</p><p>Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.</p><p>Heart rate variability</p><p>Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.</p><p>Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.</p><p>Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.</p><p>Hematocrit</p><p>Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.</p><p>Hemoglobin A1c</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Henagliflozin</p><p>Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.</p><p>Hepatocyte nuclear factor 1B</p><p>Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.</p><p>High-density lipoprotein cholesterol</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.</p><p>hs-CRP</p><p>High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.</p><p>Hyperlipidemia</p><p>Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.</p><p>Hypoglycemia</p><p>Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.</p><p>Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.</p><p>Islet transplantation in Korea, Lee 1165–1170.</p><p>Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.</p><p>Hypomagnesemia</p><p>Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.</p><p>Ideal cardiovascular health</p><p>The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.</p><p>IDegLira</p><p>Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.</p><p>IGHG1</p><p>Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.</p><p>IGlarLixi</p><p>Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.</p><p>Imeglimin</p><p>Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.</p><p>Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.</p><p>Inflammation</p><p>Regulatory T cells protect against diabetic cardiomyopathy in <i>db/db</i> mice, Zhang 1191–1201.</p><p>Influence factors</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Injection</p><p>Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12-month follow-up: Japanese real-world data, Horii 1578–1584.</p><p>Insulin</p><p>Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.</p><p>Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.</p><p>Insulin autoimmune syndrome</p><p>Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.</p><p>Insulin infusion systems</p><p>Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.</p><p>Insulin-like growth factor-1</p><p>Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.</p><p>Insulin resistance</p><p>The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.</p><p>Insulin secretion</p><p>Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.</p><p>Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.</p><p>Insulin secretory capacity</p><p>Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.</p><p>Insulin sensitivity</p><p>Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.</p><p>Intermittent fasting</p><p>Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.</p><p>Intermittently scanned continuous glucose monitoring</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Internet of things</p><p>Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.</p><p>Intestine</p><p>Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.</p><p>Islets of Langerhans transplantation</p><p>Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.</p><p>Islet transplantation in Korea, Lee 1165–1170.</p><p>JDCP study</p><p>Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.</p><p>Kidney complications</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Kidney function</p><p>Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.</p><p>Large-scale claims database</p><p>Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.</p><p>Latent autoimmune diabetes in adults</p><p>New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.</p><p>L-dopa</p><p>Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.</p><p>Left ventricular diastolic dysfunction</p><p>The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.</p><p>Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.</p><p>Letter to the Editor</p><p>Longitudinal association of sedentary time with diabetes mellitus and markers of glucose metabolism in middle-aged and older adults: The Hisayama Study, Tsuda 245–246.</p><p>Comment on the article titled “Association of the triglyceride-glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus patients: A retrospective cross-sectional study”, Naharci 517–518.</p><p>Comment on a recent article titled ‘Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia’, Clissold 790.</p><p>Long-term safety of alginate-poly-L-ornithine microcapsules, enveloping human islet allografts, into nonimmunosuppressed patients with type 1 diabetes mellitus, Calafiore 1700–1701.</p><p>Maturity-onset diabetes of the young: A proposal for updated nomenclature, Tosur 1818–1819.</p><p>Coexistence of high visceral fat area and sarcopenia and atherosclerotic markers in older patients with diabetes: Is there an association?, Saleh 1820.</p><p>Lifestyle interventions</p><p>Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.</p><p>Lipid</p><p>Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.</p><p>Lipid metabolism</p><p>The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.</p><p>Lipid profile</p><p>Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.</p><p>Lipoatrophic diabetes</p><p>A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.</p><p>Liver steatosis</p><p>Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria—NAGALA study, Sakai 1788–1796.</p><p>Liver transplantation</p><p>Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.</p><p>Low birthweight</p><p>Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.</p><p>Low-carbohydrate diet</p><p>Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.</p><p>Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.</p><p>Low-density lipoprotein cholesterol</p><p>Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.</p><p>Lysosome</p><p>Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.</p><p>Machine learning</p><p>Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.</p><p>Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.</p><p>Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.</p><p>Macrophages</p><p>Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.</p><p>Malignant neoplasms</p><p>Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.</p><p>Marfan syndrome</p><p>Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.</p><p>Maternally inherited diabetes and deafness</p><p>Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.</p><p>Maturity-onset diabetes of the young</p><p>Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.</p><p>Mean blood glucose</p><p>Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.</p><p>Mendelian randomization</p><p>Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.</p><p>Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.</p><p>Meta-analysis</p><p>Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.</p><p>Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.</p><p>Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.</p><p>Metabolic bariatric surgery</p><p>Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.</p><p>Metabolic dysfunction-associated fatty liver diseases</p><p>Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.</p><p>Metabolic dysfunction-associated steatotic liver disease</p><p>Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.</p><p>Metabolic outcomes</p><p>Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.</p><p>Metabolic syndrome</p><p>The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.</p><p>METTL3</p><p>METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.</p><p>Microalbuminuria</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>MicroRNAs</p><p>Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.</p><p>microRNA-194</p><p>Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.</p><p>miR-30a-3p</p><p><i>Cordyceps cicadae</i> polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.</p><p>miR-488-3p</p><p>MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.</p><p>MiRNA let7d-5p</p><p>High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.</p><p>Mitiglinide/voglibose fixed-dose combination tablet</p><p>Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.</p><p>Molecular diagnosis</p><p>Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.</p><p>Mood</p><p>An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.</p><p>Mortality</p><p>Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.</p><p>Mortality rate</p><p>Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.</p><p>Mortality risk</p><p>Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.</p><p>Multimorbidity</p><p>Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.</p><p>Muscle strength</p><p>Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.</p><p>Myocardial function</p><p>Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.</p><p>Neonatal</p><p>Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.</p><p>Neonatal diabetes</p><p>Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.</p><p>Neovascular glaucoma</p><p>Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.</p><p>Nerve conduction</p><p>Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.</p><p>Nerve conduction studies</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.</p><p>Netrin-1</p><p>Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.</p><p>New-onset diabetes mellitus</p><p>Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.</p><p>Nitrosamines</p><p>Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.</p><p>Nocturia</p><p>Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.</p><p>Nomograms</p><p>A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.</p><p>Nonalcoholic fatty liver disease</p><p>Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.</p><p>Nonalcoholic fatty liver disease</p><p>Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.</p><p>Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.</p><p>Novel variants</p><p>Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.</p><p>Nutrition</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.</p><p>Obesity</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.</p><p>Observational studies</p><p>Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.</p><p>Occupational health</p><p>Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.</p><p>Older adults</p><p>Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.</p><p>Online calculator</p><p>Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.</p><p>Opportunistic case finding</p><p>External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.</p><p>Oral</p><p>Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.</p><p>Oral antidiabetic drugs</p><p>Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.</p><p>Oral cancer</p><p>Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.</p><p>Oral glucose tolerance test</p><p>Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.</p><p>Oral semaglutide</p><p>Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.</p><p>PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.</p><p>Orthostatic hypotension</p><p>Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.</p><p>Outcome</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Oxidative stress</p><p>Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.</p><p>Pancreatic β-cell</p><p>Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.</p><p>Pancreatic β-cells</p><p>Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.</p><p>Parkin</p><p>METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.</p><p>Patient-reported outcomes</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>People with type 2 diabetes</p><p>The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.</p><p>Percutaneous coronary intervention</p><p>Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.</p><p>Peripheral nerve function</p><p>Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.</p><p>Permeability</p><p>Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.</p><p>Pharmacoepidemiology</p><p>Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.</p><p>Pharmacotherapy</p><p>A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.</p><p>Pharmacovigilance</p><p>A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.</p><p>Plantar pressure</p><p>Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.</p><p>Plasma glucose</p><p>Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.</p><p>Polygenic risk scores</p><p>Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.</p><p><i>Polygonatum sibiricum</i> polysaccharide</p><p><i>Polygonatum sibiricum</i> (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.</p><p>Polypharmacy</p><p>Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.</p><p>Population attributable fraction</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Post-load plasma glucose</p><p>Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.</p><p>Postnatal</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Postprandial period</p><p>Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.</p><p>Prediabetes</p><p>Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.</p><p>External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.</p><p>Prediabetes progression</p><p>High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.</p><p>Prediabetes regression</p><p>High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.</p><p>Prediction</p><p>Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.</p><p>Prediction model</p><p>Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.</p><p>Prediction of onset of diabetes</p><p>Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.</p><p>Pregnancy</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Pregnancy outcome</p><p>Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.</p><p>Prenatal</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Progestin and adipoQ receptor 3</p><p>Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.</p><p>Prohibitin2</p><p>Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.</p><p>Prospective studies</p><p>PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.</p><p>PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.</p><p>Protein catabolism</p><p>Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.</p><p>Proteinuria</p><p>Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.</p><p>Public health</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Quantitative flow ratio</p><p>Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.</p><p>Reactive hyperemia index</p><p>Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.</p><p>Reactive oxygen species</p><p><i>Polygonatum sibiricum</i> (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.</p><p>Real-world data</p><p>Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.</p><p>Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.</p><p>Real-world evidence</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Regulatory T cells</p><p>Regulatory T cells protect against diabetic cardiomyopathy in <i>db/db</i> mice, Zhang 1191–1201.</p><p>Remnant cholesterol</p><p>Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.</p><p>Remote pressure measurement</p><p>Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.</p><p>Renal cyst</p><p>Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.</p><p>Resistant starch</p><p>Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.</p><p>Resistin</p><p>Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.</p><p>Ribosomal protein S26</p><p>Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.</p><p>Risk</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Risk prediction models</p><p>External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.</p><p>Salt restriction</p><p>Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.</p><p>Sarcopenic obesity</p><p>Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.</p><p>Screening</p><p>Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.</p><p>Screening methods</p><p>Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.</p><p>Self-management</p><p>Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.</p><p>Semaglutide</p><p>PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.</p><p>A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.</p><p>Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.</p><p>Semicarbazide-sensitive amine oxidase</p><p>The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.</p><p>Serum amyloid A</p><p>Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.</p><p>Serum uric acid</p><p>Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.</p><p>Severe atherothrombotic brain infarction</p><p>Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.</p><p>SGLT2 inhibitor</p><p>A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.</p><p>Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.</p><p>Sitagliptin phosphate</p><p>Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.</p><p>Slowly progressive type 1 diabetes</p><p>New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.</p><p>Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.</p><p>Small dense low-density lipoprotein cholesterol</p><p>Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.</p><p>Social deprivation</p><p>Social deprivation and diabetic kidney disease: A European view, Casey 541–556.</p><p>Socioeconomic status</p><p>Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.</p><p>Sodium–glucose cotransporter 2 inhibitor</p><p>Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.</p><p>Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.</p><p>Sodium–glucose cotransporter 2 inhibitors</p><p>Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.</p><p>Small dense low-density lipoprotein cholesterol</p><p>Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.</p><p>Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.</p><p>South Africa</p><p>Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.</p><p>Statin</p><p>Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.</p><p>Steroid injection</p><p>Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.</p><p>Steroid myopathy</p><p>Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.</p><p>Stratification</p><p>What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.</p><p>Sulfonylurea</p><p>Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.</p><p>Survival</p><p>Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.</p><p>Sympathetic skin response</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Systematic Coronary Risk Evaluation 2-Diabetes risk</p><p>Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.</p><p>Tanshinone IIA</p><p>Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.</p><p>Tehran Lipid and Glucose Study</p><p>Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.</p><p>Texture analysis</p><p>Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.</p><p>Tezepelumab</p><p>A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.</p><p>Therapeutic inertia</p><p>Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.</p><p>The Simple Diagnostic Criteria for Diabetic Polyneuropathy</p><p>Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.</p><p>Thrombospondin-1</p><p>Relationship between elevated circulatingthrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.</p><p>Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.</p><p>Tolerability</p><p>Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.</p><p>Transition</p><p>Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.</p><p>Treatment</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Treatment – Education</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Treatment response</p><p>Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.</p><p>Triglyceride-glucose index</p><p>Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.</p><p>TXNIP/NLRP3 inflammasome</p><p>Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.</p><p>Type 1 diabetes</p><p>Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.</p><p>Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.</p><p>Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.</p><p>Type 1 diabetes mellitus</p><p>Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.</p><p>Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.</p><p>Type 2</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Type 2 diabetes</p><p>Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.</p><p>Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.</p><p>Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.</p><p>Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.</p><p>Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.</p><p>Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.</p><p>Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.</p><p>PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.</p><p>Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.</p><p>Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.</p><p>Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.</p><p>Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.</p><p>Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.</p><p>Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.</p><p>Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.</p><p>Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.</p><p>Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.</p><p>Type 2 diabetes mellitus</p><p>Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.</p><p>The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.</p><p>Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.</p><p>High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.</p><p>Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2diabetes mellitus, Imada 843–850.</p><p>Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.</p><p>Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.</p><p>Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.</p><p>Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.</p><p>Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.</p><p>Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.</p><p>Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.</p><p>Type 2 diabetes susceptibility genes</p><p>Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.</p><p>Update</p><p>Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations, Ha 285–287.</p><p>Interplay of cardiovascular health and diabetes: Insights into weight management and risk reduction, Hsu 707–710.</p><p>Advances in diagnostic methods for early-stage diabetic polyneuropathy, Naruse 820–822.</p><p>An update of contemporary insulin therapy, Tsai 1000–1002.</p><p>Clinical lessons for diabetes treatment from the COVID-19 pandemic, Hamamoto 1363–1364.</p><p>Clinical challenges in early pregnancy in Japan: An update on gestational diabetes, Sugiyama 1729–1731.</p><p>Uric acid</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.</p><p>Uric acid-to-high-density lipoprotein cholesterol ratio</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.</p><p>Urinary myo-inositol</p><p>Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.</p><p>Vaccine</p><p>Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.</p><p>Variation in hemoglobin A1c</p><p>Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.</p><p>Vascular adhesion protein-1</p><p>The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.</p><p>Visceral fat area</p><p>Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.</p><p>Vitamin D</p><p>Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.</p><p>Waist circumference</p><p>The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.</p><p>Weight loss</p><p>Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.</p><p>Weight reduction</p><p>Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.</p><p>Wound healing</p><p>MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.</p><p>XOR inhibitor</p><p>Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.</p><p>Young-onset diabetes</p><p>Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.</p><p>Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.</p>","PeriodicalId":51250,"journal":{"name":"Journal of Diabetes Investigation","volume":"15 12","pages":"1841-1861"},"PeriodicalIF":3.1000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdi.14374","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Investigation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jdi.14374","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
50-g Oral glucose challenge test
Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.
β-Cell dysfunction
Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.
β-Cells
Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.
β-Cell mass
Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.
Accuracy
Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.
Acyl-coenzyme A synthetase long-chain family member 4
Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.
Adherence
Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.
Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.
Aging
Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.
Alcohol drinking
The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.
Aldehyde dehydrogenase 2
Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.
Algorithm
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes—2nd edition (English version), Bouchi 1326–1342.
Alzheimer's disease-like complications of DM
Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.
Angiopoietin-like 4
Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.
Antidiabetic drugs
Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.
Anti-inflammatory activity
High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.
Anti-oxidative activity
High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.
Area under the C-peptide curve
Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.
Arginine vasopressin deficiency
Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.
Arterial stiffness
Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.
Asia
Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.
Aspirin
Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.
Asprosin
The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.
Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.
Asthma
A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.
Atherosclerosis
High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.
Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.
Autoimmunity
Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.
Autophagy
Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.
Average age at death
Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.
Average real variability
Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.
Behavioral change
Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.
Beta-cell function
Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.
Bioinformatics
Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.
Bioinformatics analysis
Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.
Biomarker
Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.
Biomarkers
The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.
Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.
Birth weight
Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.
Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.
Blind
Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.
Blood glucose
Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.
Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.
A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.
Blood glucose monitors
Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.
Body composition
Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.
Body mass index
Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.
Calpain-2
Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.
Cancer
Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.
Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.
Cardiovascular autonomic neuropathy
Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.
Cardiovascular disease
Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.
Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.
Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.
Cardiovascular diseases
Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.
Casual blood glucose
Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.
Cause of death
Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.
CCP
Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.
Cell encapsulation
Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.
Cesarean
Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.
Children
Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.
Children and adolescents
Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.
China
Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.
Chinese Han population
Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.
Cholesterol efflux
High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.
Chorea
Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.
Chronic kidney disease
Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.
Chronic kidney disease progression
Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.
Circ_0068087
Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.
Claims analysis
Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.
Claims data
Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.
Clinical
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.
Clinical epidemiology
Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.
Clopidogrel
Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.
Coefficient of variation
Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.
Coefficient of variation of R-R intervals
Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.
Cognition
Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.
Cognitive impairment
Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.
Cohort study
Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.
Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.
Combined approaches
Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.
Commentary
Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes, Takahashi 63–66.
Dipeptidyl peptidase-4 inhibition targeting vascular senescence as a novel treatment for atherosclerosis, Yen 143–144.
Glucose-dependent insulinotropic polypeptide receptor systems in the hypothalamus and the brainstem regulate feeding and weight through distinct pathways, Yada 283–284.
Advancements and challenges in pancreatic islet transplantation: Insights from the Collaborative Islet Transplant Registry, Lee 423–425.
Deciphering the causal tapestry between cardiorespiratory fitness and type 2 diabetes mellitus, Ko 426–428.
Birthweight and risk of diabetes in later life, Sheu 557–558.
Effects of dipeptidyl peptidase-4 inhibition in vivo: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management, Yasuda 704–706.
Gut microbiota dysbiosis as a novel pathogenic factor of diabetic peripheral neuropathy, Niimi 817–819.
Commentary on association of glycemic index and glycemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality, Hsieh 1545–1547.
Regulation of glucose and energy metabolism through actions of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, Zenimaru 1725–1726.
Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.
Continuous glucose monitoring
Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.
Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.
Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.
Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.
Possible etiological role of impaired endogenous double strand RNA editing in β-cells in type 1 diabetes, Imai 1171–1173.
A sneak peek into chronic glucose exposure and insulin secretion impairment through translatome, Helena 1174–1176.
Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.
Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.
Continuous subcutaneous insulin infusion
Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.
Corneal confocal microscopy
Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.
Cortisol
An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.
COVID-19
Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.
Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.
COVID-19 pandemic
Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.
C-peptide index
Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.
Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.
Critically ill
Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.
Cross-sectional studies
Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.
Cross-sectional study
Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.
Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.
Diabetes
Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.
Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.
Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.
Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.
Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.
Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.
Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.
Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.
Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.
Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.
Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.
Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.
Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.
Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.
Diabetes complications
Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.
Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.
Diabetes duration
Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.
Diabetes mellitus
Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.
Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.
Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.
Social deprivation and diabetic kidney disease: A European view, Casey 541–556.
Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.
Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.
Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.
Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.
Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.
Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.
Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.
A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.
A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.
Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.
Diabetes mellitus type 1
Islet transplantation in Korea, Lee 1165–1170.
Diabetes mellitus, type 2
Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.
Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.
PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.
Diabetes patient
Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.
Diabetes therapy-related quality of life
Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.
Diabetic cardiomyopathy
Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.
Regulatory T cells protect against diabetic cardiomyopathy in db/db mice, Zhang 1191–1201.
Diabetic complications
The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.
Diabetic education
Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.
Diabetic foot
What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.
Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.
Diabetic foot ulcer recurrence
Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.
Diabetic ketoacidosis
Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.
Diabetic kidney disease
Social deprivation and diabetic kidney disease: A European view, Casey 541–556.
Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.
Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.
Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.
Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.
Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.
Diabetic macular edema
Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.
Diabetic nephropathy
Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.
Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.
Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.
METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.
Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.
Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.
Diabetic neuropathy
Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.
Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.
Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.
Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.
Diabetic peripheral neuropathy
Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.
Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.
Diabetic polyneuropathies
Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.
Diabetic retinopathy
Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.
Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.
Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.
Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.
Diabetic striatopathy
Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.
Diabetics with critical limb ischemia
Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.
Diabetic symmetric sensorimotor polyneuropathy
Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253
Diet
Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.
Dietary intervention
Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.
Dietary therapy
Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.
Digital platform
Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.
Doxorubicin
Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.
DPNCheck
Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.
East Asians
Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.
Eating behavior
An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.
Eating behaviors
Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.
Editorial
Common metabolite for microangiopathy in Japanese and European populations, Shojima 523–524.
The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigma, Seino 1533–1536.
The roles of output clock genes in regulating glucose metabolism, Taguchi 1707–1710.
Elderly
Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.
Embryonic lethal abnormal visual-like protein 1
Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.
Empagliflozin
Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.
EPAC
Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.
Epigenetic change
Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.
Epilepsy
Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.
Estimated glomerular filtration rate
Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.
Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.
Ethnicity
Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.
Executive function
Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.
Fasting plasma glucose
Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.
Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.
Fenofibrate
Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.
Flash glucose monitoring
Fresh autologous blood transfusion.
Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.
Foot ulcer
What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.
Frailty
Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.
Fulminant type 1 diabetes
Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.
GAD antibody
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.
Gastrectomy
Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.
Gastrointestinal diseases
Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.
Gene editing
Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.
Generalized lipodystrophy
Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.
Genetic insulin resistance syndrome
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.
Genetics and pathogenesis
Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.
Genome-wide association studies
Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.
Gestational diabetes
The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.
Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.
Gestational diabetes mellitus
Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.
Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.
Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.
Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.
Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.
Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.
Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.
Gestational weight gain
Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.
Glomerular filtration rate
Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.
Glucagon
Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.
Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.
Glucagon-like peptide-1
Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.
Glucagon-like peptide 1 receptor agonist
Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.
Glucogenic action
Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.
Glucokinase
Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.
Glucose
Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.
Glucose metabolism
Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.
Glucose-stimulated insulin secretion
Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.
Glutamic acid decarboxylase.
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.
Glycated albumin
Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.
Glycated hemoglobin
Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.
Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.
Glycemia risk index
Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.
Glycemic control
Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.
Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.
Glycemic metrics in Japanese isCGM users—Analysis by diabetes type and therapy, Ogawa 1483–1488.
Glycemic management
The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.
Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.
Glycemic variability
Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.
Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.
Glycosylated hemoglobin
Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.
Growth
Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.
Handgrip strength
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.
Haptoglobin
Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.
HbA1c
Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.
HbA1c degradation
Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.
HbA1c trajectory
Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.
HbA1c variability
Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.
Health care costs
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.
Healthcare quality assessment
Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.
Health resources
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.
Healthy volunteers
Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.
Heart failure
Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.
Heart rate variability
Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.
Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.
Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.
Hematocrit
Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.
Hemoglobin A1c
Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.
Henagliflozin
Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.
Hepatocyte nuclear factor 1B
Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.
High-density lipoprotein cholesterol
Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.
hs-CRP
High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.
Hyperlipidemia
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.
Hypoglycemia
Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.
Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.
Islet transplantation in Korea, Lee 1165–1170.
Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.
Hypomagnesemia
Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.
Ideal cardiovascular health
The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.
IDegLira
Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.
IGHG1
Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.
IGlarLixi
Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.
Imeglimin
Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.
Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.
Inflammation
Regulatory T cells protect against diabetic cardiomyopathy in db/db mice, Zhang 1191–1201.
Influence factors
Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.
Injection
Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12-month follow-up: Japanese real-world data, Horii 1578–1584.
Insulin
Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.
Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.
Insulin autoimmune syndrome
Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.
Insulin infusion systems
Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.
Insulin-like growth factor-1
Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.
Insulin resistance
The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.
Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.
Insulin secretion
Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.
Insulin secretory capacity
Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.
Insulin sensitivity
Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.
Intermittent fasting
Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.
Internet of things
Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.
Intestine
Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.
Islets of Langerhans transplantation
Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.
Islet transplantation in Korea, Lee 1165–1170.
JDCP study
Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.
Kidney complications
Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.
Kidney function
Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.
Large-scale claims database
Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.
Latent autoimmune diabetes in adults
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.
L-dopa
Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.
Left ventricular diastolic dysfunction
The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.
Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.
Letter to the Editor
Longitudinal association of sedentary time with diabetes mellitus and markers of glucose metabolism in middle-aged and older adults: The Hisayama Study, Tsuda 245–246.
Comment on the article titled “Association of the triglyceride-glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus patients: A retrospective cross-sectional study”, Naharci 517–518.
Comment on a recent article titled ‘Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia’, Clissold 790.
Long-term safety of alginate-poly-L-ornithine microcapsules, enveloping human islet allografts, into nonimmunosuppressed patients with type 1 diabetes mellitus, Calafiore 1700–1701.
Maturity-onset diabetes of the young: A proposal for updated nomenclature, Tosur 1818–1819.
Coexistence of high visceral fat area and sarcopenia and atherosclerotic markers in older patients with diabetes: Is there an association?, Saleh 1820.
Lifestyle interventions
Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.
Lipid
Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.
Lipid metabolism
The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.
Lipid profile
Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.
Lipoatrophic diabetes
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.
Liver steatosis
Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria—NAGALA study, Sakai 1788–1796.
Liver transplantation
Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.
Low birthweight
Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.
Low-carbohydrate diet
Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.
Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.
Low-density lipoprotein cholesterol
Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.
Lysosome
Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.
Machine learning
Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.
Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.
Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.
Macrophages
Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.
Malignant neoplasms
Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.
Marfan syndrome
Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.
Maternally inherited diabetes and deafness
Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.
Maturity-onset diabetes of the young
Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.
Mean blood glucose
Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.
Mendelian randomization
Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.
Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.
Meta-analysis
Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.
Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.
Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.
Metabolic bariatric surgery
Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.
Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.
Metabolic outcomes
Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.
Metabolic syndrome
The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.
METTL3
METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.
Microalbuminuria
Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.
Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.
MicroRNAs
Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.
microRNA-194
Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.
miR-30a-3p
Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.
Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.
Molecular diagnosis
Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.
Mood
An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.
Mortality
Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.
Mortality rate
Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.
Mortality risk
Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.
Multimorbidity
Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.
Muscle strength
Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.
Myocardial function
Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.
Neonatal
Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.
Neonatal diabetes
Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.
Neovascular glaucoma
Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.
Nerve conduction
Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.
Nerve conduction studies
Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.
Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.
Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.
Netrin-1
Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.
New-onset diabetes mellitus
Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.
Nitrosamines
Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.
Nocturia
Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.
Nomograms
A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.
Nonalcoholic fatty liver disease
Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.
Nonalcoholic fatty liver disease
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.
Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.
Novel variants
Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.
Nutrition
Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.
Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.
Obesity
Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.
A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.
Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.
Observational studies
Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.
Occupational health
Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.
Older adults
Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.
Online calculator
Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.
Opportunistic case finding
External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.
Oral
Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.
Oral antidiabetic drugs
Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.
Oral cancer
Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.
Oral glucose tolerance test
Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.
Oral semaglutide
Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.
PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.
Orthostatic hypotension
Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.
Outcome
Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.
Oxidative stress
Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.
Pancreatic β-cell
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.
Pancreatic β-cells
Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.
Parkin
METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.
Patient-reported outcomes
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.
People with type 2 diabetes
The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.
Percutaneous coronary intervention
Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.
Peripheral nerve function
Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.
Permeability
Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.
Pharmacoepidemiology
Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.
Pharmacotherapy
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.
Pharmacovigilance
A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.
Plantar pressure
Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.
Plasma glucose
Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.
Polygenic risk scores
Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.
Polygonatum sibiricum polysaccharide
Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.
Polypharmacy
Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.
Population attributable fraction
Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.
Post-load plasma glucose
Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.
Postnatal
Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.
Postprandial period
Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.
Prediabetes
Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.
External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.
Prediabetes progression
High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.
Prediabetes regression
High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.
Prediction
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.
Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.
Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.
Prediction model
Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.
Prediction of onset of diabetes
Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.
Pregnancy
Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.
Pregnancy outcome
Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.
Prenatal
Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.
Progestin and adipoQ receptor 3
Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.
Prohibitin2
Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.
Prospective studies
PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.
PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.
Protein catabolism
Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.
Proteinuria
Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.
Public health
Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.
Quantitative flow ratio
Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.
Reactive hyperemia index
Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.
Reactive oxygen species
Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.
Real-world data
Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.
Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.
Real-world evidence
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.
Regulatory T cells
Regulatory T cells protect against diabetic cardiomyopathy in db/db mice, Zhang 1191–1201.
Remnant cholesterol
Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.
Remote pressure measurement
Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.
Renal cyst
Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.
Resistant starch
Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.
Resistin
Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.
Ribosomal protein S26
Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.
Risk
Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.
Risk prediction models
External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.
Salt restriction
Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.
Sarcopenic obesity
Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.
Screening
Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.
Screening methods
Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.
Self-management
Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.
Semaglutide
PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.
A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.
Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.
Semicarbazide-sensitive amine oxidase
The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.
Serum amyloid A
Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.
Serum uric acid
Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.
Severe atherothrombotic brain infarction
Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.
SGLT2 inhibitor
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.
Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.
Sitagliptin phosphate
Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.
Slowly progressive type 1 diabetes
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.
Small dense low-density lipoprotein cholesterol
Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.
Social deprivation
Social deprivation and diabetic kidney disease: A European view, Casey 541–556.
Socioeconomic status
Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.
Sodium–glucose cotransporter 2 inhibitor
Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.
Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.
Sodium–glucose cotransporter 2 inhibitors
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.
Small dense low-density lipoprotein cholesterol
Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.
South Africa
Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.
Statin
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.
Steroid injection
Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.
Steroid myopathy
Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.
Stratification
What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.
Sulfonylurea
Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.
Survival
Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.
Sympathetic skin response
Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.
Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.
Tanshinone IIA
Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.
Tehran Lipid and Glucose Study
Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.
Texture analysis
Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.
Tezepelumab
A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.
Therapeutic inertia
Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.
The Simple Diagnostic Criteria for Diabetic Polyneuropathy
Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.
Thrombospondin-1
Relationship between elevated circulatingthrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.
Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.
Tolerability
Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.
Transition
Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.
Treatment
Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.
Treatment – Education
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.
Treatment response
Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.
Triglyceride-glucose index
Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.
TXNIP/NLRP3 inflammasome
Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.
Type 1 diabetes
Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.
Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.
Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.
Type 1 diabetes mellitus
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.
Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.
Type 2
Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.
Type 2 diabetes
Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.
Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.
Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.
Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.
Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.
Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.
Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.
PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.
Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.
Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.
Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.
Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.
Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.
Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.
Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.
Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.
Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.
Type 2 diabetes mellitus
Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.
The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.
Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.
High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.
Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2diabetes mellitus, Imada 843–850.
Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.
Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.
Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.
Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.
Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.
Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.
Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.
Type 2 diabetes susceptibility genes
Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.
Update
Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations, Ha 285–287.
Interplay of cardiovascular health and diabetes: Insights into weight management and risk reduction, Hsu 707–710.
Advances in diagnostic methods for early-stage diabetic polyneuropathy, Naruse 820–822.
An update of contemporary insulin therapy, Tsai 1000–1002.
Clinical lessons for diabetes treatment from the COVID-19 pandemic, Hamamoto 1363–1364.
Clinical challenges in early pregnancy in Japan: An update on gestational diabetes, Sugiyama 1729–1731.
Uric acid
Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.
Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.
Uric acid-to-high-density lipoprotein cholesterol ratio
Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.
Urinary myo-inositol
Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.
Vaccine
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.
Variation in hemoglobin A1c
Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.
Vascular adhesion protein-1
The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.
Visceral fat area
Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.
Vitamin D
Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.
Waist circumference
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.
Weight loss
Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.
Weight reduction
Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.
期刊介绍：
Journal of Diabetes Investigation is your core diabetes journal from Asia; the official journal of the Asian Association for the Study of Diabetes (AASD). The journal publishes original research, country reports, commentaries, reviews, mini-reviews, case reports, letters, as well as editorials and news. Embracing clinical and experimental research in diabetes and related areas, the Journal of Diabetes Investigation includes aspects of prevention, treatment, as well as molecular aspects and pathophysiology. Translational research focused on the exchange of ideas between clinicians and researchers is also welcome. Journal of Diabetes Investigation is indexed by Science Citation Index Expanded (SCIE).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
